Brief: Irlab Is Granted Additional Patent For Drug Candidate Mesdopetam

IRLAB Therapeutics AB

04/09/2024 06:39

Sept 4 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * IS GRANTED ADDITIONAL PATENT FOR DRUG CANDIDATE MESDOPETAM
THAT
EXPANDS ITS PATENT PROTECTION

Source text for Eikon:  ID:nMFN5S383Q 
Further company coverage:  IRLABa.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))